Landing Page Header Background

Advocacy and Outreach

Advocacy and Outreach

SIR advocates on behalf of its members and interventional radiology before Congress, insurance carriers and other key decision-makers. The society also reaches around the world and out to partners across corporate, public and private sectors to ensure the story of interventional radiology is spread through a range of communication channels. 


Latest news

Surprise billing legislative activity update

The House of Representatives Education and Labor Committee marked up H.R.5800, the“ Ban Surprise Billing Act ”on Feb. 11and the House Ways and Means Committee marked up H.R. 5826, the “ Consumer Protections Against Surprise Medical Bills Act ” on Feb.12.

The House Energy and Commerce Committee and the Senate are still working on their versions of surprise billing legislation. One main issue in the surprise billing debate is whether to use benchmark payment rates or independent dispute resolution (IDR). The Ways and Means Committee bill allows IDR after a thirty-day negotiation period and uses the median in-network rate as the starting point for mediation. The White House prefers to avoid the IDR method because of potential increases in health care costs. Congress wants to add surprise billing to the Medicare extenders package before the May 22nd deadline.

FDA final guidance about peripheral vascular atherectomy devices

The Food and Drug Administration (FDA) announced the availability of a final guidance in the Federal Register on February 13, 2020, about “Peripheral Vascular Atherectomy Devices-Premarket Notification Submissions.” This guidance provides recommendations for premarket submissions for a new or modified peripheral vascular atherectomy device.

FDA Nomination Requests

The Food and Drug Administration (FDA) posted the following requests for FDA Advisory Board and Standard Committee nominations:

All nominations for membership should be submitted electronically by logging into the FDA Advisory Nomination Portal at or by mail to Advisory Committee Oversight and Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103, Silver Spring, MD 20993-0002. Information about becoming a member on an FDA advisory committee can also be obtained by visiting FDA's website.

If you are interested in applying for any of these FDA Advisory Committees, please contact Judi Buckalew, SIR Director of Government Relations at jbuckalew@sirweb.org for more information and/ or assistance. SIR needs to know if you intend to submit an application or submit comments to the FDA.

FDA Reclassifies Radiological and Medical Imaging Devices

The Food and Drug Administration (FDA) posted a series of notices on January 22, 2020, about reclassifying radiological and medical imaging devices from Class III to Class II. To learn more about each reclassification please select from the links below.

  • Radiological Computer-Aided Triage and Notification Software: Read More
  • Radiological Computer-Assisted Diagnostic Software for Lesions Suspicious for Cancer: Read More
  • Medical Image Analyzers: Read More

FDA seeks information about the use of radioactive drugs

The Food and Drug Administration (FDA)  posted a notice in the Federal Register on January 20, 2020, seeking public comments on information collection requirements contained in regulations governing the use of radioactive drugs for basic informational research for FDA’s Radioactive Drug Research Committees. Public comment and data collection will be open until March 23, 2020.

SIR signs onto CSM letter about scope of practice implications for non-physician led health practices

SIR joined with the American Medical Association (AMA) to send a letter to CMS on January 16, 2020. The letter expresses concern with the far-reaching implications of CMS’ request for information regarding physician-led health care and the impact changes will have on state scope of practice laws.

FDA Announces Public Workshop on Role of AI in Radiological Imaging

The Food and Drug Administration (FDA) has announced they are hosting a public workshop entitled "Evolving Role of Artificial Intelligence in Radiological Imaging." The intent of this public workshop is to discuss emerging applications of Artificial Intelligence (AI) in radiological imaging including AI devices intended to automate the diagnostic radiology workflow as well as guided image acquisition. The purpose of the workshop is to work with interested stakeholders to identify the benefits and risks associated with the use of AI in radiological imaging and to discuss best practices for the validation of AI-automated radiological imaging software and image acquisition devices. 

Information can be found here: https://www.fda.gov/medical-devices/workshops-conferences-medical-devices/public-workshop-evolving-role-artificial-intelligence-radiological-imaging-02252020-02262020

 

 

Government affairs

Your voice in Washington, D.C.

The Society of Interventional Radiology's government relations and health policy staff members work to further the interests of society members by advocating on their behalf before Congress, regulatory and federal agencies and the White House.

SIR members play a vital role in this process. The government affairs section will guide you through our advocacy efforts and the major policy issues that affect the society.


SIRPAC

SIRPAC is the Society of Interventional Radiology Political Action Committee, a nonpartisan body dedicated to supporting political candidates who may help advance SIR’s public policy mission and legislative initiatives. SIRPAC elevates the profile of interventional radiology, SIR and society members among representatives in Congress by enabling the society to better leverage its lobbying efforts in Washington, D.C.

Corporate relations

Over 40 years ago, all-new categories of devices enabled clinical pioneers to attempt the first true, minimally invasive, interventional techniques and inaugurate a tradition of partnership in improving outcomes.

SIR collaborates today with commercial partners through multiple avenues to reveal innovations in clinical devices, pharmaceuticals and combination technologies. Our corporate programs work to provide opportunities to align businesses with minimally-invasive providers, advance healthcare capabilities and benefit the patients we serve together. Learn more about how we partner with industry.

Media relations

SIR facilitates access to experts and resources to help news outlets report on minimally invasive, image-guided therapeutic treatments. Find our latest media statements, our media contacts and more in the SIR newsroom.

The Society of Interventional Radiology media relations staff works with members of the news media to facilitate access to many resources and helps reporters cover issues about minimally invasive, image-guided therapeutic treatments.


Our communications department staff:

  • Handles your inquiries
  • Sets up interviews with an expert
  • Serves as a source for story ideas regarding the latest advances in interventional radiology treatments.

Practice resources

From the impact of healthcare reform to patient relations, SIR provides tips and advice for real-world issues facing today's medical practices. SIR offers toolkists, standards, guidelines and other valuable resources to equip you for success in quality reimbursement and advocacy.

Find practice resources

Developing a global specialty

SIR’s goal is to build a global network to support IR everywhere. Building relationships, identifying  regional needs and creating regional programmatic opportunities.

 

Learn more

Partnership with industry can improve outcomes

Many businesses provide tools and services critical to the delivery of healthcare. Discover how companies can collaborate more closely with the society, engage better with the interventional radiology community and help make SIR’s mission possible.

Meet CAP

Advance IR through advocacy

A donation to SIRPAC allows SIR to build relationships with key members of the House and Senate and their staffs to advance IR through  legislation that promotes patient access to IR services.

Donate now

SIR International Scholars Program

Growing IR's international profile

The SIR International Scholars Program enables physicians within 10 years of completion of training, who are practicing outside North America, an opportunity to attend the SIR Annual Scientific Meeting. Offering physicians from other nations a chance to train and learn from their peers means that they can return to their countries to teach and enhance patient care. The program fosters professional networking through meeting participation, focused programming and optional observerships before or after annual meeting.

 

Go global